Safety and Systemic Exposure Study of BL-7010 in Well-Controlled Celiac Patients.
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of different amounts of BL-7010 in single
oral administration and in repeated oral administration to well-controlled celiac patients.
Another purpose is to evaluate if BL-7010 is absorbed by the body or not.